Solvonis to Present at WTR Conference

AI SummaryClose X

Solvonis Therapeutics plc announced that its CEO will present at the Water Tower Research Virtual Insights Conference on September 22-23, 2026, as part of its U.S. investor engagement strategy following WTR's commissioned research coverage initiated in July 2026. The presentation will cover Solvonis' CNS portfolio, progress on key assets SVN-001, SVN-002, SVN-114, and SVN-015, and the strategic importance of the U.S. market for its pipeline, particularly for SVN-002. The company will also hold one-to-one investor meetings to discuss its strategy and pipeline, aiming to enhance its profile among U.S. investors and facilitate a more informed assessment of its development strategy and differentiated pipeline relative to U.S.-listed CNS companies.

Disclaimer*

UK 100

Latest directors dealings